REFERENCES
1. Chinese Society of Parkinson’s Disease and Movement Disorders. Diagnosis and treatment of Parkinson disease: a review. 4th ed . Chin J Neurol 2020;53:973-86. (in Chinese)
2. Armstrong MJ, Okun MS. Diagnosis and treatment of Parkinson disease: a review. JAMA 2020;323:548-60.
3. Berendse HW, Ponsen MM. Detection of preclinical Parkinson’s disease along the olfactory trac(t). J Neural Transm Suppl 2006;70:321-5.
4. Yilmaz R, Berg D. Transcranial B-mode sonography in movement disorders. Int Rev Neurobiol 2018;143:179-212.
5. Hilker R, Voges J, Weisenbach S, et al. Subthalamic nucleus stimulation restores glucose metabolism in associative and limbic cortices and in cerebellum: evidence from a FDG-PET study in advanced Parkinson’s disease. J Cereb Blood Flow Metab 2004;24:7-16.
6. Potashkin J, Huang X, Becker C, Chen H, Foltynie T, Marras C. Understanding the links between cardiovascular disease and Parkinson’s disease. Mov Disord 2020;35:55-74.
7. Vital A, Lepreux S, Vital C. Peripheral neuropathy and parkinsonism: a large clinical and pathogenic spectrum. J Peripher Nerv Syst 2014;19:333-42.
8. Hernandez Fustes OJ, Hernandez Fustes OJ. Sensory neuropathy in Parkinson disease: electrodiagnostic evaluation. Neurodiagn J 2020;60:177-84.
9. Müller T, Renger K, Kuhn W. Levodopa-associated increase of homocysteine levels and sural axonal neurodegeneration. Arch Neurol 2004;61:657-60.
10. Toth C, Breithaupt K, Ge S, et al. Levodopa, methylmalonic acid, and neuropathy in idiopathic Parkinson disease. Ann Neurol 2010;68:28-36.
11. Zis P, Grünewald RA, Chaudhuri RK, Hadjivassiliou M. Peripheral neuropathy in idiopathic Parkinson’s disease: a systematic review. J Neurol Sci 2017;378:204-9.
12. Manca D, Cossu G, Murgia D, et al. Reversible encephalopathy and axonal neuropathy in Parkinson’s disease during duodopa therapy. Mov Disord 2009;24:2293-4.
13. Paul DA, Qureshi ARM, Rana AQ. Peripheral neuropathy in Parkinson’s disease. Neurol Sci 2020;41:2691-701.
14. Lee JJ, Baik JS. Peripheral neuropathy in de novo patients with Parkinson’s disease. Yonsei Med J 2020;61:1050-3.
15. Themistocleous AC, Ramirez JD, Serra J, Bennett DL. The clinical approach to small fibre neuropathy and painful channelopathy. Pract Neurol 2014;14:368-79.
16. Cossu G, Melis M. The peripheral nerve involvement in Parkinson disease: a multifaceted phenomenon. Parkinsonism Relat Disord 2016;25:17-20.
17. Ferreira N, Gonçalves NP, Jan A, et al. Trans-synaptic spreading of alpha-synuclein pathology through sensory afferents leads to sensory nerve degeneration and neuropathic pain. Acta Neuropathol Commun 2021;9:31.
18. La Vitola P, Balducci C, Baroni M, et al. Peripheral inflammation exacerbates α-synuclein toxicity and neuropathology in Parkinson’s models. Neuropathol Appl Neurobiol 2021;47:43-60.
19. Merola A, Rosso M, Romagnolo A, et al. Peripheral neuropathy as marker of severe Parkinson’s disease phenotype. Mov Disord 2017;32:1256-8.
20. Doherty KM, van de Warrenburg BP, Peralta MC, et al. Postural deformities in Parkinson’s disease. Lancet Neurol 2011;10:538-49.
21. Ali F, Matsumoto JY, Hassan A. Camptocormia: etiology, diagnosis, and treatment response. Neurol Clin Pract 2018;8:240-8.
22. Ashour R, Tintner R, Jankovic J. Striatal deformities of the hand and foot in Parkinson’s disease. Lancet Neurol 2005;4:423-31.
23. Barra J, Marquer A, Joassin R, et al. Humans use internal models to construct and update a sense of verticality. Brain 2010;133:3552-63.
24. Pandey S, Kumar H. Assessment of striatal & postural deformities in patients with Parkinson’s disease. Indian J Med Res 2016;144:682-8.
25. Srivanitchapoom P, Hallett M. Camptocormia in Parkinson’s disease: definition, epidemiology, pathogenesis and treatment modalities. J Neurol Neurosurg Psychiatry 2016;87:75-85.
26. Ruttiman R, Eltorai AEM, Daniels AH. Etiology and management of spinal deformity in patients with Parkinson’s disease. Int J Spine Surg 2018;12:15-21.
27. Margraf NG, Wrede A, Rohr A, et al. Camptocormia in idiopathic Parkinson’s disease: a focal myopathy of the paravertebral muscles. Mov Disord 2010;25:542-51.
28. Tatu L, Bogousslavsky J. Camptocormia: new signs in an old syndrome. Front Neurol Neurosci 2018;42:87-95.
29. Margraf NG, Wrede A, Deuschl G, Schulz-Schaeffer WJ. Pathophysiological concepts and treatment of camptocormia. J Parkinsons Dis 2016;6:485-501.
30. Wijemanne S, Jimenez-Shahed J. Improvement in dystonic camptocormia following botulinum toxin injection to the external oblique muscle. Parkinsonism Relat Disord 2014;20:1106-7.
31. Jocson A, Lew M. Use of botulinum toxin in Parkinson’s disease. Parkinsonism Relat Disord 2019;59:57-64.
32. Bertram KL, Stirpe P, Colosimo C. Treatment of camptocormia with botulinum toxin. Toxicon 2015;107:148-53.
33. Graham JG, Oppenheimer DR. Orthostatic hypotension and nicotine sensitivity in a case of multiple system atrophy. J Neurol Neurosurg Psychiatry 1969;32:28-34.
34. Cao Z, Wu Y, Liu G, et al. Differential diagnosis of multiple system atrophy-Parkinsonism and Parkinson’s disease using α-synuclein and external anal sphincter electromyography. Front Neurol 2020;11:1043.
35. Linder J, Libelius R, Nordh E, Holmberg B, Stenlund H, Forsgren L. Anal sphincter electromyography in patients with newly diagnosed idiopathic parkinsonism. Acta Neurol Scand 2012;126:248-55.
36. Vodusek DB. Sphincter EMG and differential diagnosis of multiple system atrophy. Mov Disord 2001;16:600-7.
37. Huang HJ, Zhu XY, Wang X, et al. The bulbocavernosus reflex in the differential diagnosis of multiple system atrophy with predominant Parkinsonism and Parkinson’s disease. Front Neurol 2017;8:697.
38. Papagiannis GI, Triantafyllou AI, Roumpelakis IM, et al. Methodology of surface electromyography in gait analysis: review of the literature. J Med Eng Technol 2019;43:59-65.
39. Chowdhury RH, Reaz MB, Ali MA, Bakar AA, Chellappan K, Chang TG. Surface electromyography signal processing and classification techniques. Sensors (Basel) 2013;13:12431-66.
40. Rissanen SM, Koivu M, Hartikainen P, Pekkonen E. Ambulatory surface electromyography with accelerometry for evaluating daily motor fluctuations in Parkinson’s disease. Clin Neurophysiol 2021;132:469-79.
41. Warabi T, Furuyama H, Sugai E, Kato M, Yanagisawa N. Gait bradykinesia in Parkinson’s disease: a change in the motor program which controls the synergy of gait. Exp Brain Res 2018;236:43-57.
42. Baradaran N, Tan SN, Liu A, et al. Parkinson’s disease rigidity: relation to brain connectivity and motor performance. Front Neurol 2013;4:67.
43. Volpe D, Spolaor F, Sawacha Z, et al. Muscular activation changes in lower limbs after underwater gait training in Parkinson’s disease: a surface emg pilot study. Gait Posture 2020;80:185-91.
44. Islam A, Alcock L, Nazarpour K, Rochester L, Pantall A. Effect of Parkinson’s disease and two therapeutic interventions on muscle activity during walking: a systematic review. NPJ Parkinsons Dis 2020;6:22.
45. Dietz V, Zijlstra W, Prokop T, Berger W. Leg muscle activation during gait in Parkinson’s disease: adaptation and interlimb coordination. Electroencephalogr Clin Neurophysiol 1995;97:408-15.
46. Albani G, Sandrini G, Künig G, et al. Differences in the EMG pattern of leg muscle activation during locomotion in Parkinson’s disease. Funct Neurol 2003;18:165-70.
47. Miller RA, Thaut MH, Mcintosh GC, Rice RR. Components of EMG symmetry and variability in parkinsonian and healthy elderly gait. Electroencephalogr Clin Neurophysiol 1996;101:1-7.
48. Francis CA, Lenz AL, Lenhart RL, Thelen DG. The modulation of forward propulsion, vertical support, and center of pressure by the plantarflexors during human walking. Gait Posture 2013;38:993-7.
49. Keloth SM, Arjunan SP, Raghav S, Kumar DK. Muscle activation strategies of people with early-stage Parkinson’s during walking. J Neuroeng Rehabil 2021;18:133.
50. Bailey CA, Corona F, Murgia M, Pili R, Pau M, Côté JN. Electromyographical gait characteristics in Parkinson’s disease: effects of combined physical therapy and rhythmic auditory stimulation. Front Neurol 2018;9:211.
51. Lang KC, Hackney ME, Ting LH, McKay JL. Antagonist muscle activity during reactive balance responses is elevated in Parkinson’s disease and in balance impairment. PLoS One 2019;14:e0211137.
52. Kugler P, Jaremenko C, Schlachetzki J, Winkler J, Klucken J, Eskofier B. Automatic recognition of Parkinson’s disease using surface electromyography during standardized gait tests. Annu Int Conf IEEE Eng Med Biol Soc 2013;2013:5781-4.
53. Lamontagne A, Richards CL, Malouin F. Coactivation during gait as an adaptive behavior after stroke. J Electromyogr Kinesiol 2000;10:407-15.
54. Kluger BM, Herlofson K, Chou KL, et al. Parkinson’s disease-related fatigue: a case definition and recommendations for clinical research. Mov Disord 2016;31:625-31.
55. Prell T, Witte OW, Grosskreutz J. Biomarkers for dementia, fatigue, and depression in Parkinson’s disease. Front Neurol 2019;10:195.
56. Schapira AHV, Chaudhuri KR, Jenner P. Non-motor features of Parkinson disease. Nat Rev Neurosci 2017;18:435-50.
57. Lazcano-Ocampo C, Wan YM, van Wamelen DJ, et al. Identifying and responding to fatigue and apathy in Parkinson’s disease: a review of current practice. Expert Rev Neurother 2020;20:477-95.
58. Nassif DV, Pereira JS. Fatigue in Parkinson’s disease: concepts and clinical approach. Psychogeriatrics 2018;18:143-50.
59. Siciliano M, Trojano L, Santangelo G, De Micco R, Tedeschi G, Tessitore A. Fatigue in Parkinson’s disease: a systematic review and meta-analysis. Mov Disord 2018;33:1712-23.
60. Roland KP, Jones GR, Jakobi JM. Daily electromyography in females with Parkinson’s disease: a potential indicator of frailty. Arch Gerontol Geriatr 2014;58:80-7.
61. Fundarò C, Gazzoni M, Pinna GD, Dallocchio C, Rainoldi A, Casale R. Is fatigue a muscular phenomenon in Parkinson’s disease? Eur J Phys Rehabil Med 2021;57:691-700.
62. Vescio B, Quattrone A, Nisticò R, Crasà M, Quattrone A. Wearable devices for assessment of tremor. Front Neurol 2021;12:680011.
63. Bhatia KP, Bain P, Bajaj N, et al. Tremor Task Force of the International Parkinson and Movement Disorder Society. Consensus statement on the classification of tremors. from the task force on tremor of the International Parkinson and Movement Disorder Society. Mov Disord 2018;33:75-87.
64. Chen KS, Chen R. Principles of electrophysiological assessments for movement disorders. J Mov Disord 2020;13:27-38.
65. Dideriksen JL, Gallego JA, Holobar A, Rocon E, Pons JL, Farina D. One central oscillatory drive is compatible with experimental motor unit behaviour in essential and Parkinsonian tremor. J Neural Eng 2015;12:046019.
66. Lorenz D, Poremba C, Papengut F, Schreiber S, Deuschl G. The psychosocial burden of essential tremor in an outpatient- and a community-based cohort. Eur J Neurol 2011;18:972-9.
67. Papengut F, Raethjen J, Binder A, Deuschl G. Rest tremor suppression may separate essential from parkinsonian rest tremor. Parkinsonism Relat Disord 2013;19:693-7.
68. Armstrong MJ, Litvan I, Lang AE, et al. Criteria for the diagnosis of corticobasal degeneration. Neurology 2013;80:496-503.
69. Shaikh AG. Tremor analysis separates Parkinson’s disease and dopamine receptor blockers induced parkinsonism. Neurol Sci 2017;38:855-63.
70. Flood MW, Jensen BR, Malling AS, Lowery MM. Increased EMG intermuscular coherence and reduced signal complexity in Parkinson’s disease. Clin Neurophysiol 2019;130:259-69.
71. Laine CM, Valero-Cuevas FJ. Parkinson’s disease exhibits amplified intermuscular coherence during dynamic voluntary action. Front Neurol 2020;11:204.
72. Gómez A, Gómez P, Palacios D, et al. A neuromotor to acoustical jaw-tongue projection model with application in Parkinson’s disease hypokinetic dysarthria. Front Hum Neurosci 2021;15:622825.
73. Chu SY, Barlow SM, Lee J, Wang J. Polar-phase indices of perioral muscle reciprocity during syllable production in Parkinson’s disease. Int J Speech Lang Pathol 2017;19:616-27.
74. Mes M, Janik P, Zalewska E, Gawel M. Motor neurons loss in Parkinson disease: an electrophysiological study (MUNE). J Electromyogr Kinesiol 2021;61:102606.
75. Barghi E, Gladden M. Motor unit number estimation in normal and parkinsonism model of medial gastrocnemius muscle in rats. Int J Mol Cell Med 2013;2:72-9.
